ChemicalsCompany
Seqens M&A Summary
Seqens has acquired 4 companies of its own, including 1 in the last 5 years. A total of 3 acquisitions came from private equity firms.
Seqens has acquired in 1 US state, and 4 countries. The Company’s most targeted sectors include life science (50%) and chemicals (25%).
Seqens Ownership
Who owns Seqens?
Seqens is owned by Ardian, Eurazeo PME, Merieux Equity Partners and SK Capital Partners. It was acquired on March 21, 2016.
Is Seqens PE-backed?
Yes. Seqens is owned by private equity investors Ardian, Eurazeo PME, Merieux Equity Partners and SK Capital Partners.
Was Seqens formerly PE-backed?
Yes. Seqens was formerly owned by 2 private investors.
Seqens Business Overview
Where is Seqens headquartered?
Seqens is headquartered in Ecully, France.
How many employees does Seqens have?
Seqens has 3,200 employees.
What sector is Seqens in?
Seqens is a chemicals company.
When was Seqens founded?
Seqens was founded in 2003.
M&A Summary
-
M&A Total Activity4
- M&A Buy Activity4
- Total Sectors Invested 3
- Total Countries Invested 4
- M&A Buy/Sell Connections 3
- M&A Advisors 1
Unlimited Searches
